Andrew James King, Chief Scientific Officer at CHINOOK THERAPEUTICS, INC. (KDNY), sold 5,000 shares at $20.00 ($100K) on 2022-08-04, disclosed to the SEC on 2022-08-05.
Open-market sale of $100k KDNY by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KDNY | SELL | 2023-02-15 | $57K | — | Filing → |
| KDNY | SELL | 2023-02-02 | $160K | — | Filing → |
| KDNY | SELL | 2023-01-04 | $258K | — | Filing → |